Cancer Pain clinical trials

Explore recruiting cancer pain clinical trials.

Recruiting cancer pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cancer Pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PARASTOP – Paracetamol with Strong Opioids. A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimizing subcutaneous FEntanyl titRation: RApid achievement of adequate exposure when treating cancer-Related paIn (FERRARI-study).

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain: a randomized controlled trial

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Prevention of opioid-induced constipation in patients with advanced cancer.

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Suboxone (buprenorphine/naloxone) versus methadone opioid rotation in patients with escalated opioid use and chronic pain: a randomized trial (SUMO study).

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

CHIPOR : Randomized phase III study evaluating hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cancer Pain trials by city

Cancer Pain in Toronto Cancer Pain in Vancouver Cancer Pain in Montreal Cancer Pain in Calgary Cancer Pain in Edmonton Cancer Pain in Ottawa Cancer Pain in Winnipeg Cancer Pain in Quebec City Cancer Pain in Hamilton Cancer Pain in Kitchener Cancer Pain in London Cancer Pain in Halifax Cancer Pain in New York Cancer Pain in Los Angeles Cancer Pain in Chicago Cancer Pain in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease